The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus: A 12-week Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial With an Open-label Glimepiride Arm.
Phase of Trial: Phase III
Latest Information Update: 11 Mar 2017
At a glance
- Drugs Liraglutide (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 28 May 2010 Actual patient number (48) added as reported by ClinicalTrials.gov.
- 28 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.